You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Boston Scientific agrees to buy a division of Bayer AG for $415m

Boston Scientific Corp. will pay $415 million to buy a division of German drug maker Bayer AG , a unit whose products include a system for removing blood clots from arteries and veins.

Boston Scientific already sells a wide range of catheters, stents, wires, and balloons that are used to treat vascular conditions, but the deal will expand the “breadth and scale” of the Natick medical-device maker’s portfolio, said Jeff Mirviss, president of its peripheral interventions unit.

Continue reading below

“Our goal is to be the clear leader in providing solutions to treat complex vascular” conditions, Mirviss said in an interview.

The sale of the Bayer Interventional division -- which was made public Thursday -- includes the AngioJet system, which is used to remove blood clots, as well as the JetStream Atherectomy System, a minimally invasive device that cleans plaque from diseased arteries, mostly in legs.

Bayer’s Interventional division is based in Minnesota and has about 350 employees. In 2013, it generated sales of $120 million, while Boston Scientific reported $7.14 billion in sales.

“We believe this transaction will enable us to reach more effectively the greater than 27 million patients worldwide who suffer from the debilitating effects of peripheral vascular disease,” Boston Scientific chief executive Mike Mahoney said in a statement.

The company said it expects to close the deal in the second half of the year.

Chris Reidy can be reached at reidy@globe.com.
Loading comments...
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.